Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Uppsala University
- License Information
-
More Information
Article History
Received: 17 July 2022
Accepted: 7 June 2023
First Online: 16 June 2023
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (Dnr 2020–00249; 2020–03-11) and adhered to the tenets of the 1964 Declaration of Helsinki and its later amendments. Each patient approved registration of medical data in the Swedish Macula Register (SMR) and additional consent for participation in the present study was not required as by the approval by the Swedish Ethical Review Authority.
: All authors approved the final manuscript and gave consent for publication.
: Author E Granstam is Advisory board member for Novartis, Bayer, Roche and Allergan and has received speaker honorarium from these companies. Authors HY Tang and M Rosén declare that they have no conflicts of interest.
